Dual influenza-RSV circulation raises winter preparedness stakes across the Americas
On January 10, 2026, the Pan American Health Organization urged governments to tighten respiratory-season readiness as seasonal influenza and respiratory syncytial virus (RSV) circulate at the same time in the region’s winter months. The signal follows an epidemiological alert that updates a December 4, 2025 advisory warning of an earlier or more intense respiratory season.
“The simultaneous circulation of influenza and RSV is a significant challenge that requires us to prioritize vaccination-which protects against severe cases that may require hospitalization-and maintain close surveillance, enabling timely action to prevent larger outbreaks and avoid hospital overcrowding,” said Dr. Marc Rondy, PAHO Regional Adviser in Epidemiology of Epidemic- and Pandemic-Prone Diseases.
The alert is aimed squarely at health ministries and public-health decision makers in the Americas, where PAHO also serves as the World Health Organization’s Regional Office for the Americas and works alongside the World Health Assembly’s governing framework to coordinate cross-border health security, financing, and standards.
What surveillance is signaling right now
PAHO’s call comes as routine influenza and respiratory virus surveillance systems, including national sentinel sites and laboratory networks, detect concurrent activity across multiple subregions. For policymakers, the key question is not only how high case numbers will climb, but whether systems can stay ahead of a combined influenza-RSV wave without triggering disruptive emergency measures.
| Indicator | Latest signal (as of Jan 10, 2026) | Geography | Operational implication |
|---|---|---|---|
| Global influenza trend | Steady rise since October 2025; A(H3N2) predominating | Multiple Northern Hemisphere countries | Expect sustained demand for testing, antivirals, and bed capacity |
| Influenza positivity | Above 10% in the Northern Hemisphere; ~20% in parts of the Caribbean | North America, Central America, Caribbean | Heightened outpatient visits and hospital admissions likely |
| Season timing | Early and rapid start | United States, Canada, United Kingdom, Spain | Earlier-than-usual staffing and surge planning windows |
| Outpatient burden | Increased visits, particularly among children | Northern Hemisphere | Potential strain on pediatric clinics and emergency departments |
| Hospitalizations | Rising, especially among older adults | Northern Hemisphere | Pressure on medical wards and long-term care interfaces |
| Overall severity | Comparable to prior seasons; no excess mortality observed to date | Regional | Focus on managing throughput rather than extreme mortality events |
| RSV activity | Gradual upward trend | Regional | Concurrent pediatric and neonatal demand may rise |
For health authorities, the surveillance picture translates into immediate operational questions: whether to activate existing winter surge plans, how quickly to mobilize additional funding, and when to trigger cross-border support arrangements under regional health-security agreements.
Who faces the highest risk of severe outcomes
While current indicators do not point to a more lethal season overall, the burden of severe disease remains highly concentrated. PAHO’s alert reiterates that protecting clinically vulnerable populations is the most effective way to blunt pressure on hospitals and intensive care units.
- Older adults, particularly those with frailty or multiple chronic conditions.
- Young children, especially infants and those born prematurely.
- Pregnant people, given elevated risks of complications from respiratory infections.
- Individuals with chronic cardiopulmonary disease, diabetes, or immunocompromise.
- Healthcare workers, due to repeated exposure and the knock-on effect of workforce absenteeism.
Targeted policies-such as prioritizing these groups for vaccination, prophylaxis and early antiviral use-are framed as central to keeping routine services functioning through the winter months.
Vaccine effectiveness and program priorities
Interim evaluations indicate current seasonal influenza vaccines are preventing hospitalizations in both adults and children. Programs that front-load vaccination for priority groups are expected to moderate admissions and preserve capacity, particularly if they are aligned with broader national immunization schedules and delivered through trusted primary care channels.
| Outcome | Estimated effectiveness | Population | Program takeaway |
|---|---|---|---|
| Prevention of hospitalization from influenza | 30-40% | Adults | Mitigates bed occupancy during peak weeks |
| Prevention of hospitalization from influenza | 75% | Children | Critical for pediatric surge control |
- Priority vaccination groups: older adults, young children, pregnant people, individuals with chronic conditions, and healthcare workers.
- COVID-19 vaccination remains part of respiratory-risk mitigation for vulnerable populations and should be integrated into winter preparedness plans rather than run as a standalone campaign.
- RSV prevention: maternal vaccination and long-acting monoclonal antibodies for newborns and infants are emphasized within regional guidance, requiring procurement decisions and clear eligibility criteria from health authorities.
For governments, the effectiveness figures are a reminder that even moderate protection at the individual level can translate into significant relief for hospitals when applied at scale through national immunization programs.
Where health systems may feel pressure first
Officials reviewing capacity plans are being urged to focus not only on total bed numbers but on the specific nodes in the system where dual influenza-RSV circulation can trigger bottlenecks.
- Pediatric emergency and inpatient services as influenza and RSV overlap among children.
- Adult medical wards and step-down units given rising admissions among older adults.
- Emergency department throughput if outpatient illness and admissions climb simultaneously.
- Long-term care and post-acute facilities due to higher vulnerability, staffing constraints, and transfer needs.
- Diagnostic capacity for influenza, RSV, and SARS-CoV-2 as integrated testing demand rises.
- Staffing resilience amid absenteeism; cross-coverage, surge pools, and flexible scheduling may be required.
Many of these pinch points sit at the interface of health and social-care policy, underscoring the need for coordination between hospital managers, primary care, and social services rather than isolated institutional responses.
Data and reporting remain the backbone of the response
PAHO’s alert places heavy emphasis on timely, high-quality data as the basis for calibrated, rather than reactive, decision-making. National reporting into regional platforms is described as both a technical and governance obligation.
- Integrated surveillance of influenza, RSV, SARS‑CoV‑2 and other respiratory viruses with weekly reporting to FluNET and FluID underpins situational awareness.
- Consistent case, hospitalization, and mortality data allow rapid recalibration of service plans when thresholds are crossed, including decisions on reallocating budgets and staff.
- Disaggregated data (age, pregnancy status, comorbidities) support equitable resource targeting and help identify where policy interventions are failing to reach priority groups.
For health ministries, this means ensuring legal reporting requirements, laboratory capacity and digital systems are aligned so that epidemiological signals can translate quickly into operational orders across public and private providers.
Policy checkpoints for the next two months
Against this backdrop, PAHO outlines a short, actionable policy horizon. Rather than a single moment of crisis, authorities are advised to plan for a series of checkpoints as the season unfolds.
| Timeframe | Operational focus | Health-system levers | Population impact |
|---|---|---|---|
| Mid-late January 2026 | Confirm surge plans as positivity exceeds seasonal baselines | Adjust staffing rosters; protect pediatric and adult bed availability | Smoother triage and reduced boarding times |
| February 2026 | Manage overlapping peaks of influenza and RSV | Scale integrated testing; optimize referral pathways; maintain vaccination outreach | Lower risk of avoidable admissions among high‑risk groups |
| Late winter 2026 | Monitor for secondary surges and localized outbreaks | Rapid redeployment of resources to affected jurisdictions | Containment of cluster-driven pressure on facilities |
These windows provide a planning backbone for cabinet-level discussions on contingency funding, emergency declarations, and cross-border coordination, should pressures escalate.
Equity gaps to watch
The alert also highlights that the benefits of vaccines, prophylaxis, and strengthened services are not evenly distributed. For governments, that translates into a test of whether existing commitments on universal health coverage and non-discrimination are being met in practice.
- Lower vaccination coverage in rural and remote areas, where cold-chain and workforce gaps can limit outreach.
- Barriers to maternal care and infant prophylaxis that limit RSV prevention benefits.
- Access constraints among Indigenous and Afro-descendant communities and across border zones.
- Information gaps where risk communication has limited reach or low trust.
Addressing these gaps requires both technical fixes-such as mobile clinics and adapted service hours-and policy choices on resource allocation, community engagement, and accountability for coverage targets.
Risk communication and everyday prevention
Finally, PAHO urges authorities to keep everyday prevention visible without resorting to alarmist messaging, emphasizing consistency with existing national guidance.
- Public messaging that emphasizes vaccination and simple respiratory hygiene has been reinforced in the latest alert.
- Guidance highlights staying home when febrile or symptomatic and using masks indoors when symptomatic to reduce transmission within households and community settings.
- Timely care-seeking for severe symptoms remains part of standard seasonal respiratory guidance for families with young children and for older adults.
With influenza and RSV now moving in tandem, the coming weeks will test whether the region’s governance frameworks, health systems, and communication strategies can work together to keep a difficult season from tipping into avoidable crisis.
